JPH0344052B2 - - Google Patents
Info
- Publication number
- JPH0344052B2 JPH0344052B2 JP60082690A JP8269085A JPH0344052B2 JP H0344052 B2 JPH0344052 B2 JP H0344052B2 JP 60082690 A JP60082690 A JP 60082690A JP 8269085 A JP8269085 A JP 8269085A JP H0344052 B2 JPH0344052 B2 JP H0344052B2
- Authority
- JP
- Japan
- Prior art keywords
- salicylate
- choline salicylate
- solid
- pharmaceutical composition
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- UDKCHVLMFQVBAA-UHFFFAOYSA-M Choline salicylate Chemical compound C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O UDKCHVLMFQVBAA-UHFFFAOYSA-M 0.000 claims description 48
- 229960002688 choline salicylate Drugs 0.000 claims description 48
- 239000000203 mixture Substances 0.000 claims description 45
- 239000007787 solid Substances 0.000 claims description 20
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 19
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 19
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 19
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 19
- 239000007909 solid dosage form Substances 0.000 claims description 14
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 229960001860 salicylate Drugs 0.000 claims description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 8
- 229920013820 alkyl cellulose Polymers 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000012439 solid excipient Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 17
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 10
- 229940072082 magnesium salicylate Drugs 0.000 description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 10
- 239000002775 capsule Substances 0.000 description 8
- 239000008187 granular material Substances 0.000 description 7
- -1 mercury ions Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000829 suppository Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229940105329 carboxymethylcellulose Drugs 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229960004889 salicylic acid Drugs 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- GQSZLMMXKNYCTP-UHFFFAOYSA-K aluminum;2-carboxyphenolate Chemical compound [Al+3].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O GQSZLMMXKNYCTP-UHFFFAOYSA-K 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BHBWPPVOZBNIGP-UHFFFAOYSA-L O[AlH]OC(=O)C1=CC=CC=C1O Chemical compound O[AlH]OC(=O)C1=CC=CC=C1O BHBWPPVOZBNIGP-UHFFFAOYSA-L 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 229910001451 bismuth ion Inorganic materials 0.000 description 2
- REKWPXFKNZERAA-UHFFFAOYSA-K bismuth;2-carboxyphenolate Chemical compound [Bi+3].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O REKWPXFKNZERAA-UHFFFAOYSA-K 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003873 salicylate salts Chemical class 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- DQKGOGJIOHUEGK-UHFFFAOYSA-M hydron;2-hydroxyethyl(trimethyl)azanium;carbonate Chemical compound OC([O-])=O.C[N+](C)(C)CCO DQKGOGJIOHUEGK-UHFFFAOYSA-M 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009491 slugging Methods 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯ãµãªãã«é
žã³ãªã³ãå«æããå®å®ãªåº
äœè¬å€çšçµæç©ã«é¢ããã
äœè¬å€çšçµæç©ã«é¢ããã
ç±³åœç¹èš±ç¬¬3069321å·æ现æžã«èšèŒãããŠãã
ããã«ããµãªãã«é žã³ãªã³ã¯æãŸããè¬çåŠçå
ã³æ²»çäžã®æ§è³ªãæããé®çå€ç©è³ªãšããŠè¯ãç¥
ãããŠãããããããªããããã®ååç©ã¯åžæ¹¿æ§
ãé«ããšããç¹æ§ãæãããã®ããã«äººéåã³å
ç©ã®ãµãªãã«é žã³ãªã³çæ³ã«ãããçµå£æäžã«æ
çšãªåºåœ¢ã®å€åã奜é©ã«è£œé ããããšãã§ããªã
ãšãã調å€äžã®éçãæãããèç¹ã50âã®çµæ¶
æ§ãµãªãã«é žã³ãªã³ãç¥ãããŠã¯ãããããã®åž
湿æ§ã¯çµæ¶ç¶ã®ååç©ã液ç¶ã«å€åãããã®ã«ç
è·¡éã®æ¹¿æ°ã§å åãªçšé«ããåžåããã湿æ°ãå
ãé€ãããã«ã©ã®ããã«åŠçããŠã液ç¶ã®ãŸãŸã§
ããããããããå®å®ãªåºåœ¢ã®å€åãé ãããã«
調å€äžäœ¿çšããããšã¯ã§ããªãã
ããã«ããµãªãã«é žã³ãªã³ã¯æãŸããè¬çåŠçå
ã³æ²»çäžã®æ§è³ªãæããé®çå€ç©è³ªãšããŠè¯ãç¥
ãããŠãããããããªããããã®ååç©ã¯åžæ¹¿æ§
ãé«ããšããç¹æ§ãæãããã®ããã«äººéåã³å
ç©ã®ãµãªãã«é žã³ãªã³çæ³ã«ãããçµå£æäžã«æ
çšãªåºåœ¢ã®å€åã奜é©ã«è£œé ããããšãã§ããªã
ãšãã調å€äžã®éçãæãããèç¹ã50âã®çµæ¶
æ§ãµãªãã«é žã³ãªã³ãç¥ãããŠã¯ãããããã®åž
湿æ§ã¯çµæ¶ç¶ã®ååç©ã液ç¶ã«å€åãããã®ã«ç
è·¡éã®æ¹¿æ°ã§å åãªçšé«ããåžåããã湿æ°ãå
ãé€ãããã«ã©ã®ããã«åŠçããŠã液ç¶ã®ãŸãŸã§
ããããããããå®å®ãªåºåœ¢ã®å€åãé ãããã«
調å€äžäœ¿çšããããšã¯ã§ããªãã
ãµãªãã«é
žã³ãªã³ã®åºåœ¢ã®èª¿å€çå€åãé ãã
ãã«å€ãã®åªåããªãããŠãããäŸãã°ãç±³åœç¹
蚱第3297529å·ã«ã¯åºäœã®çæç©ãçãããµãªã
ã«é žã³ãªã³ãšç¡«é žãã°ãã·ãŠã ã®æ··åç©ãé瀺ã
ããŠãããç±³åœç¹èš±ç¬¬3326760å·ã¯ããªã¬ã©ã¯ã
ãã³é žãšã®åžçäœã«é¢ãããã®ã§ãããç±³åœç¹èš±
第3759980å·ã¯ãµãªãã«é žã³ãªã³ãšãµãªãã«é žã
ã°ãã·ãŠã ãšã®åäžååç©ïŒåºäœïŒã®åœ¢æã«é¢ã
ããã®ã§ãããããããªãããå®å®ãªãåºåœ¢ã®å€
åãæäŸãããšããåé¡ã解決ãããã®ãšããŠèš
èŒãããäžèšã®æ¹æ³ã¯ãã©ããæªã 調å€äžæºè¶³ãª
ãã®ãšã¯èšããªããæ²»çç®çãéæããããã«å¿
èŠãšãããå åãªæ²»çäžã®å質ãæãããŸããã
ãåæ¥äžã®äŸ¡å€ãæãã補åãšããŠåžè²©ããããš
ãå¯èœã«ãããããªé·æã«ãããå åãªå®å®æ§ã
ãã€ããµãªãã«é žã³ãªã³ã®åºåœ¢å€åã¯æªã é ãã
ãŠããªãã
ãã«å€ãã®åªåããªãããŠãããäŸãã°ãç±³åœç¹
蚱第3297529å·ã«ã¯åºäœã®çæç©ãçãããµãªã
ã«é žã³ãªã³ãšç¡«é žãã°ãã·ãŠã ã®æ··åç©ãé瀺ã
ããŠãããç±³åœç¹èš±ç¬¬3326760å·ã¯ããªã¬ã©ã¯ã
ãã³é žãšã®åžçäœã«é¢ãããã®ã§ãããç±³åœç¹èš±
第3759980å·ã¯ãµãªãã«é žã³ãªã³ãšãµãªãã«é žã
ã°ãã·ãŠã ãšã®åäžååç©ïŒåºäœïŒã®åœ¢æã«é¢ã
ããã®ã§ãããããããªãããå®å®ãªãåºåœ¢ã®å€
åãæäŸãããšããåé¡ã解決ãããã®ãšããŠèš
èŒãããäžèšã®æ¹æ³ã¯ãã©ããæªã 調å€äžæºè¶³ãª
ãã®ãšã¯èšããªããæ²»çç®çãéæããããã«å¿
èŠãšãããå åãªæ²»çäžã®å質ãæãããŸããã
ãåæ¥äžã®äŸ¡å€ãæãã補åãšããŠåžè²©ããããš
ãå¯èœã«ãããããªé·æã«ãããå åãªå®å®æ§ã
ãã€ããµãªãã«é žã³ãªã³ã®åºåœ¢å€åã¯æªã é ãã
ãŠããªãã
äžè¬çã«èšã€ãŠãæ¬çºæã«åŸãã°ããµãªãã«é
ž
ã³ãªã³ã¯å°ãªããšãïŒäŸ¡ã®åå䟡ãæããéå±ã®
ãµãªãã«é žå¡©ãšãã«ã«ããã·äœçŽã¢ã«ãã«ã»ã«ã
ãŒã¹ãšãæ··åããããšã«ãã€ãŠåºäœç¶æ ã§å®å®å
ãããã奜ãŸããéå±ã®ãµãªãã«é žå¡©ã¯ãã¢ã«ã
ããŠã ããã¹ãã¹ãã«ã«ã·ãŠã åã³ãã°ãã·ãŠã
ã®ãµãªãã«é žå¡©ã§ããããµãªãã«é žã³ãªã³ã®éå±
ãµãªãã«é žå¡©ã«å¯Ÿããã¢ã«æ¯ã¯å¥œé©ã«ã¯çŽ0.8ïŒ
ïŒä¹è³1.2ïŒïŒã®éã§ãããæé©ã«ã¯ãµãªãã«é ž
ã³ãªã³åã³éå±ã®ãµãªãã«é žå¡©ã®çã¢ã«éã䜿çš
ããã
ã³ãªã³ã¯å°ãªããšãïŒäŸ¡ã®åå䟡ãæããéå±ã®
ãµãªãã«é žå¡©ãšãã«ã«ããã·äœçŽã¢ã«ãã«ã»ã«ã
ãŒã¹ãšãæ··åããããšã«ãã€ãŠåºäœç¶æ ã§å®å®å
ãããã奜ãŸããéå±ã®ãµãªãã«é žå¡©ã¯ãã¢ã«ã
ããŠã ããã¹ãã¹ãã«ã«ã·ãŠã åã³ãã°ãã·ãŠã
ã®ãµãªãã«é žå¡©ã§ããããµãªãã«é žã³ãªã³ã®éå±
ãµãªãã«é žå¡©ã«å¯Ÿããã¢ã«æ¯ã¯å¥œé©ã«ã¯çŽ0.8ïŒ
ïŒä¹è³1.2ïŒïŒã®éã§ãããæé©ã«ã¯ãµãªãã«é ž
ã³ãªã³åã³éå±ã®ãµãªãã«é žå¡©ã®çã¢ã«éã䜿çš
ããã
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãéå±ãµãªãã«é
ž
å¡©ãšå ±ã«æ·»å ããããšã«ãã€ãŠãåèšæ··åç©ã®å®
å®æ§ãŸãã¯å¯¿åœãåå ããããšããå¹æãåŸãã
ãããã®å®å®åå¹æãåŸãããã«æ·»å ãã¹ãã«ã«
ããã·ã¡ãã«ã»ã«ããŒã¹ã®éã¯åºç¯å²ã«ããã€ãŠ
å¯èœã§ãããã奜é©ã«ã¯çŽ2.5ééïŒ ä¹è³25éé
ïŒ ã§ããã溶液ã«äœã¬ãã«ã®æ°Žåãååšããæã«
ã¯ãçµæç©ã®ãµãªãã«é žã³ãªã³ã¬ãã«ãæ倧éã«
ããããã«ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã®æ·»å ã¯
å°éã奜ãŸããã
å¡©ãšå ±ã«æ·»å ããããšã«ãã€ãŠãåèšæ··åç©ã®å®
å®æ§ãŸãã¯å¯¿åœãåå ããããšããå¹æãåŸãã
ãããã®å®å®åå¹æãåŸãããã«æ·»å ãã¹ãã«ã«
ããã·ã¡ãã«ã»ã«ããŒã¹ã®éã¯åºç¯å²ã«ããã€ãŠ
å¯èœã§ãããã奜é©ã«ã¯çŽ2.5ééïŒ ä¹è³25éé
ïŒ ã§ããã溶液ã«äœã¬ãã«ã®æ°Žåãååšããæã«
ã¯ãçµæç©ã®ãµãªãã«é žã³ãªã³ã¬ãã«ãæ倧éã«
ããããã«ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã®æ·»å ã¯
å°éã奜ãŸããã
æ¬çºæã®çµæç©ãå³ã¡ããµãªãã«é
žã³ãªã³ãšãµ
ãªãã«é žéå±å¡©ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãš
ã®æ··åç©ã¯å šãŠå®å®ã§ã也ç¥ãããæµåæ§ã®ãã
ïŒfreeãflowingïŒç²æ«ç¶ã®ãµãªãã«é žã³ãªã³ãæ
äŸãããå šãŠã®å Žåã«ããããããã®ä¹Ÿç¥ç²æ«
ã¯ãåœæ¥è ã«åšç¥ã®æ¹æ³ã«ãã€ãŠèª¿å€çã«å¥œé©ãª
ã«ãã»ã«ãé¡ç²ãé å€åã³åº§è¬ã®è£œé ã«æçã§ã
ããããããµãªãã«é žã³ãªã³ã®æ°èŠã®ä¹Ÿç¥åºäœç²
æ«ç¶çµæç©ã¯ãããã®ãããã®å€åã§ã人éåã³
åç©ã«å¯ŸããŠäœ¿çšããããšãåºæ¥ãã
ãªãã«é žéå±å¡©ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãš
ã®æ··åç©ã¯å šãŠå®å®ã§ã也ç¥ãããæµåæ§ã®ãã
ïŒfreeãflowingïŒç²æ«ç¶ã®ãµãªãã«é žã³ãªã³ãæ
äŸãããå šãŠã®å Žåã«ããããããã®ä¹Ÿç¥ç²æ«
ã¯ãåœæ¥è ã«åšç¥ã®æ¹æ³ã«ãã€ãŠèª¿å€çã«å¥œé©ãª
ã«ãã»ã«ãé¡ç²ãé å€åã³åº§è¬ã®è£œé ã«æçã§ã
ããããããµãªãã«é žã³ãªã³ã®æ°èŠã®ä¹Ÿç¥åºäœç²
æ«ç¶çµæç©ã¯ãããã®ãããã®å€åã§ã人éåã³
åç©ã«å¯ŸããŠäœ¿çšããããšãåºæ¥ãã
æ¬çºæã®æ··åç©ïŒãµãªãã«é
žã³ãªã³ãšãµãªãã«
é žãã°ãã·ãŠã ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãš
ã®æ··åç©ïŒãçšããŠè£œé ãããæ°èŠã®åºåœ¢å€å
ã¯ããµãªãã«é žã³ãªã³æäžã«ãããŠç¹å¥ã®å¥œãŸã
ãå©ç¹ãæäŸãããå³ã¡ãåªããççåŠçèæ§ã
ã»ãšãã©ç¡ãå¯äœçšãæŽã«ã¯æ²»ççã«å åãªéã®
ãµãªãã«é žã³ãªã³ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹
åã³ã¢ã«ãããŠã ããã¹ãã¹ãã«ã«ã·ãŠã ãŸãã¯
ãã°ãã·ãŠã ã€ãªã³ãã圢æãããé©åœãªååç©
ãå«æããé å€ãã«ãã»ã«ãé¡ç²ããŸãã¯åº§è¬ã®
æäžåŸã®äººéãŸãã¯åç©ã«ãããè¡äžãµãªãã¬ãŒ
ãã€ãªã³æ¿åºŠã®éãããªäžæã«ãã€ãŠç«èšŒããã
åªããæ²»çå¹æã§ããã
é žãã°ãã·ãŠã ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãš
ã®æ··åç©ïŒãçšããŠè£œé ãããæ°èŠã®åºåœ¢å€å
ã¯ããµãªãã«é žã³ãªã³æäžã«ãããŠç¹å¥ã®å¥œãŸã
ãå©ç¹ãæäŸãããå³ã¡ãåªããççåŠçèæ§ã
ã»ãšãã©ç¡ãå¯äœçšãæŽã«ã¯æ²»ççã«å åãªéã®
ãµãªãã«é žã³ãªã³ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹
åã³ã¢ã«ãããŠã ããã¹ãã¹ãã«ã«ã·ãŠã ãŸãã¯
ãã°ãã·ãŠã ã€ãªã³ãã圢æãããé©åœãªååç©
ãå«æããé å€ãã«ãã»ã«ãé¡ç²ããŸãã¯åº§è¬ã®
æäžåŸã®äººéãŸãã¯åç©ã«ãããè¡äžãµãªãã¬ãŒ
ãã€ãªã³æ¿åºŠã®éãããªäžæã«ãã€ãŠç«èšŒããã
åªããæ²»çå¹æã§ããã
ãµãªãã«é
žã³ãªã³ãšãµãªãã«é
žéå±å¡©ãšã«ã«ã
ãã·ã¡ãã«ã»ã«ããŒã¹ãšã®åçŽãªæ··åç©ã¯ãã®æ
åã§ããååç©ãæ··åããããšã«ãã€ãŠåŸãã
ãããããããµãªãã«é žã³ãªã³ã¯å€§æ°äžã«æã
ãšã極ãçæéãã也ç¥ç¶æ ãç¶æããªãããã
æ··åç©ã¯å¥œãŸããã¯ãŸããµãªãã«é žã³ãªã³ã®æ¿å
溶液ãäœæããããã«ãµãªãã«é žéå±å¡©åã³ã«ã«
ããã·ã¡ãã«ã»ã«ããŒã¹ãå ããŠãã溶åªãèžçº
ãããããšã«ãã€ãŠåŸãããã
ãã·ã¡ãã«ã»ã«ããŒã¹ãšã®åçŽãªæ··åç©ã¯ãã®æ
åã§ããååç©ãæ··åããããšã«ãã€ãŠåŸãã
ãããããããµãªãã«é žã³ãªã³ã¯å€§æ°äžã«æã
ãšã極ãçæéãã也ç¥ç¶æ ãç¶æããªãããã
æ··åç©ã¯å¥œãŸããã¯ãŸããµãªãã«é žã³ãªã³ã®æ¿å
溶液ãäœæããããã«ãµãªãã«é žéå±å¡©åã³ã«ã«
ããã·ã¡ãã«ã»ã«ããŒã¹ãå ããŠãã溶åªãèžçº
ãããããšã«ãã€ãŠåŸãããã
æ¬çºæã«ããæ°èŠã®æ··åç©ã®ç²æ«ã¯å解ããã«
é·æéæµåæ§ã®ããåºäœã®ç¹åŸŽãä¿æãããåèš
ã®ç²æ«ãçšããŠè£œé ãããäŸãã°é å€ãã«ãã»
ã«ãé¡ç²ãŸãã¯åº§è¬ã®ãããªåºåœ¢ã®å€åã¯å®å®ã§
é·æéãã®å¹åãç¶æãããæ¬çºæã«ãããæ··å
ç©ãéæŸãããããªç¿ã«åããé·æé倧æ°äžã«æ
ããå Žåãããã®ç²æ«ã¯å解ããã«å ã®æµåæ§ã
æããåºäœã®æ§ç¶ãä¿æããã調å€çã«å¥œãŸãã
åºåœ¢ã®å€åã«è£œå€ãããå è£ ãããŠå®€æž©ã§ä¿åšã
ããå Žåããããã®è¬å€ã¯åªã«ïŒå¹Žéã¯å®å®ã§ã
ãã
é·æéæµåæ§ã®ããåºäœã®ç¹åŸŽãä¿æãããåèš
ã®ç²æ«ãçšããŠè£œé ãããäŸãã°é å€ãã«ãã»
ã«ãé¡ç²ãŸãã¯åº§è¬ã®ãããªåºåœ¢ã®å€åã¯å®å®ã§
é·æéãã®å¹åãç¶æãããæ¬çºæã«ãããæ··å
ç©ãéæŸãããããªç¿ã«åããé·æé倧æ°äžã«æ
ããå Žåãããã®ç²æ«ã¯å解ããã«å ã®æµåæ§ã
æããåºäœã®æ§ç¶ãä¿æããã調å€çã«å¥œãŸãã
åºåœ¢ã®å€åã«è£œå€ãããå è£ ãããŠå®€æž©ã§ä¿åšã
ããå Žåããããã®è¬å€ã¯åªã«ïŒå¹Žéã¯å®å®ã§ã
ãã
æ¬çºæã®æ°èŠç²æ«ãåŸãããã«ã¯ãä»ã®éå±ã€
ãªã³ã䜿çšããããšãã§ãããã奜ãŸããéå±ã€
ãªã³ã¯ã¢ã«ãããŠã ããã¹ãã¹ãã«ã«ã·ãŠã ãå
ã³ãã°ãã·ãŠã ã®ã€ãªã³ã§ãããæµåæ§ãæãã
æ°èŠã®åºäœç²æ«ã圢æããããã«éå±ã€ãªã³ã¯å°
ãªããšãäºäŸ¡ã®åå䟡ãæããããšãå¿ èŠãšãã
ãç¹ã«æ³šæãèŠãããçæç©ã¯å»çäžã®çšéã«äœ¿
çšããããããéå±ã€ãªã³ã®é©æ§ã¯ãã®å®å šæ§å
ã³æŽ»æ§ã«ãã€ãŠéå®ããããåŸã€ãŠæ°Žéã€ãªã³ã
ç çŽ ã€ãªã³ãŸãã¯æ£è ã®å®å šæ§ã«åœ±é¿ããåºæã®
æ¯æ§ãæãããã®ä»ã®éå±ã€ãªã³ãçšããããšã¯
åºæ¥ãããããã¯ç¹ã«é€å€ãããŠããã
ãªã³ã䜿çšããããšãã§ãããã奜ãŸããéå±ã€
ãªã³ã¯ã¢ã«ãããŠã ããã¹ãã¹ãã«ã«ã·ãŠã ãå
ã³ãã°ãã·ãŠã ã®ã€ãªã³ã§ãããæµåæ§ãæãã
æ°èŠã®åºäœç²æ«ã圢æããããã«éå±ã€ãªã³ã¯å°
ãªããšãäºäŸ¡ã®åå䟡ãæããããšãå¿ èŠãšãã
ãç¹ã«æ³šæãèŠãããçæç©ã¯å»çäžã®çšéã«äœ¿
çšããããããéå±ã€ãªã³ã®é©æ§ã¯ãã®å®å šæ§å
ã³æŽ»æ§ã«ãã€ãŠéå®ããããåŸã€ãŠæ°Žéã€ãªã³ã
ç çŽ ã€ãªã³ãŸãã¯æ£è ã®å®å šæ§ã«åœ±é¿ããåºæã®
æ¯æ§ãæãããã®ä»ã®éå±ã€ãªã³ãçšããããšã¯
åºæ¥ãããããã¯ç¹ã«é€å€ãããŠããã
æ¬çºæã®æ°èŠæ··åç©ãé å€ãšããŠåœ¢æãããã
ã®äžè¬çãªæ¹æ³ã以äžã«è©³è¿°ããã
ã®äžè¬çãªæ¹æ³ã以äžã«è©³è¿°ããã
é å€ã®ããšã«ãªãç²æ«ã¯é©åœéã®éžã°ãã掻æ§
æåïŒäŸãã°ããµãªãã«é žã³ãªã³ãšãµãªãã«é žã
ã°ãã·ãŠã ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãšã®æ··
åç©ïŒãã©ã¯ããŒã¹ã柱ç²ããããªãã³ãŸãã¯ã
ã®ä»ã®èª¿å€çã«å¥œé©ãªçšéå€ãšæ··åãã該混åç©
ã«çµåå€ïŒbinderïŒåã³æœ€æ»å€ïŒlubricantïŒã
å ãããçµåå€åã³æœ€æ»å€ã¯åœæ¥è ã«ããç¥ãã
ãŠãã調å€çã«å¥œãŸããé å€çšã®çµåå€åã³æœ€æ»
å€ãçšããã次ã«äžèšæ··åç©ã¯ãšã¿ããŒã«ãçšã
ãŠé ç²ã也ç¥ããã也ç¥ãããé¡ç²ç©è³ªã¯ç¶ããŠ
é©åœãªå€§ãããšåœ¢ã®é å€ã«å§ç·ããããå¥ã®é å€
補é æ³ã§ã¯ãé©åœéã®äžèšæŽ»æ§ç©è³ªãã©ã¯ããŒ
ã¹ãã¹ã¯ããŒã¹ã柱ç²ãçµæ¶æ§ãã¯ãã»ã«ããŒã¹
ã®ãããªèª¿å€çã«å¥œé©ãªçšéå€ãšæ··åãã該混å
ç©ãã¹ã©ããžã³ã°æ³ïŒsluggingïŒãšããŠåšç¥ã®æ¹
æ³ã«ãã也ç¥ããé å€ã«å§çž®ããã¹ã©ããžã³ã°ã
ããé å€ãç²ç ããŠç¬¬16å·ç±³åœæšæºã¡ãã·ãŠä»¥äž
ã®å€§ããã®é¡ç²ç²æ«ã圢æããåèšé¡ç²ç²æ«ãé©
åœãªå€§ãããšåœ¢ã®é å€ã«å§çž®ãããã«ãã»ã«ã¯é©
åœãªã«ãã»ã«ã«æå¹æåãåç¬ãŸãã¯çšéå€ãšæ··
åããŠå å¡«ããããšã«ãã補é ããããé å€ã®å Ž
åã«èšèŒãããåèšã®çšéå€ã¯ãã®å Žåã«ãçšã
ãããšãã§ããã
æåïŒäŸãã°ããµãªãã«é žã³ãªã³ãšãµãªãã«é žã
ã°ãã·ãŠã ãšã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãšã®æ··
åç©ïŒãã©ã¯ããŒã¹ã柱ç²ããããªãã³ãŸãã¯ã
ã®ä»ã®èª¿å€çã«å¥œé©ãªçšéå€ãšæ··åãã該混åç©
ã«çµåå€ïŒbinderïŒåã³æœ€æ»å€ïŒlubricantïŒã
å ãããçµåå€åã³æœ€æ»å€ã¯åœæ¥è ã«ããç¥ãã
ãŠãã調å€çã«å¥œãŸããé å€çšã®çµåå€åã³æœ€æ»
å€ãçšããã次ã«äžèšæ··åç©ã¯ãšã¿ããŒã«ãçšã
ãŠé ç²ã也ç¥ããã也ç¥ãããé¡ç²ç©è³ªã¯ç¶ããŠ
é©åœãªå€§ãããšåœ¢ã®é å€ã«å§ç·ããããå¥ã®é å€
補é æ³ã§ã¯ãé©åœéã®äžèšæŽ»æ§ç©è³ªãã©ã¯ããŒ
ã¹ãã¹ã¯ããŒã¹ã柱ç²ãçµæ¶æ§ãã¯ãã»ã«ããŒã¹
ã®ãããªèª¿å€çã«å¥œé©ãªçšéå€ãšæ··åãã該混å
ç©ãã¹ã©ããžã³ã°æ³ïŒsluggingïŒãšããŠåšç¥ã®æ¹
æ³ã«ãã也ç¥ããé å€ã«å§çž®ããã¹ã©ããžã³ã°ã
ããé å€ãç²ç ããŠç¬¬16å·ç±³åœæšæºã¡ãã·ãŠä»¥äž
ã®å€§ããã®é¡ç²ç²æ«ã圢æããåèšé¡ç²ç²æ«ãé©
åœãªå€§ãããšåœ¢ã®é å€ã«å§çž®ãããã«ãã»ã«ã¯é©
åœãªã«ãã»ã«ã«æå¹æåãåç¬ãŸãã¯çšéå€ãšæ··
åããŠå å¡«ããããšã«ãã補é ããããé å€ã®å Ž
åã«èšèŒãããåèšã®çšéå€ã¯ãã®å Žåã«ãçšã
ãããšãã§ããã
é¡ç²ã¯é å€ã®è£œé æ³ã§è¿°ã¹ãæ¹æ³ã§åŸãããé¡
ç²ãé å€ã«å§çž®ããã«ãããã調å€ããã®ãæãŸ
ããããã®å Žåæå¹æåã®æ¿åºŠã¯åäœæçšéïŒïœ
ãŸãã¯æšæºçåäœæçšéãšããŠé è¬ãããŠããé
éã«åºããŠèª¿ç¯ãããã
ç²ãé å€ã«å§çž®ããã«ãããã調å€ããã®ãæãŸ
ããããã®å Žåæå¹æåã®æ¿åºŠã¯åäœæçšéïŒïœ
ãŸãã¯æšæºçåäœæçšéãšããŠé è¬ãããŠããé
éã«åºããŠèª¿ç¯ãããã
座è¬ã¯æå¹æåãé©åœéã®ã³ã³ã¢ãã¿ãŒãåå
é1500以äžã®ããªãšãã¬ã³ã°ãªã³ãŒã«ãŸãã¯é©åœ
ãªåº§è¬åºå€ãšæ··åããŠè£œé ãããã次ã«åº§è¬ã¯ã
ãç¥ãããå€åã«æåãããã
é1500以äžã®ããªãšãã¬ã³ã°ãªã³ãŒã«ãŸãã¯é©åœ
ãªåº§è¬åºå€ãšæ··åããŠè£œé ãããã次ã«åº§è¬ã¯ã
ãç¥ãããå€åã«æåãããã
æ°èŠã®æ··åç©ãå«æããäžèšã®åºåœ¢å€åã人é
åã³åç©ã®æ²»çã«çšããæã¯ãæ²»çäžå¿ èŠãšãã
ãïŒæ¥åã®éãïŒæ¥ã«ïŒåä¹è³ïŒåã«åããŠæäž
ããã
åã³åç©ã®æ²»çã«çšããæã¯ãæ²»çäžå¿ èŠãšãã
ãïŒæ¥åã®éãïŒæ¥ã«ïŒåä¹è³ïŒåã«åããŠæäž
ããã
以äžãå®æœäŸã«ãã€ãŠæ¬çºæãããå
·äœçã«èª¬
æãããããããæ¬çºæã®ç¯å²ã¯å®æœäŸã®åã ã®
èšèŒã«éå®ããããã®ã§ã¯ãªãã
æãããããããæ¬çºæã®ç¯å²ã¯å®æœäŸã®åã ã®
èšèŒã«éå®ããããã®ã§ã¯ãªãã
å®æœäŸ ïŒ
é©åœãªãã©ã¹ã³ã«çé
žæ°ŽçŽ ã³ãªã³165ïœãæ°Ž500
c.c.äžã«æº¶è§£ãã溶液ãå ¥ããããã«ãµãªãã«é ž
138ïœãäžå®ã®æ¹æäžã«äºé žåççŽ ã®ããã ã¡ã
æ¢ããŸã§å ãããããããŠèª¿è£œãããµãªãã«é žã³
ãªã³æº¶æ¶²ãæ¿çž®ããŠããµãªãã«é žã³ãªã³ã®æ¿åºŠã
ééæ¯ã§å°ãªããšã溶液ã®90ïŒ ã«ãªãããã«ããŸ
ã10ïŒ ä»¥äžã®æ°Žãæ®ããªãããã«ããããã®æº¶æ¶²
ã«ãµãªãã«é žãã°ãã·ãŠã ç¡æ°Žç©300ïœãå ãã
æ··åç©ãæ¹æããããã°ãããããšããŒã¹ãç¶ã®
ãããŸãã圢æãããããã¬ã©ã¹ã®è¡šé¢äžã«å¡åž
ããŠä¹Ÿç¥ããããããæ°æéã§ç¡¬ãåºäœç©è³ªãåŸ
ããããããç²ç ããŠåŸ®çŽ°ãªç²æ«ã«ããŠé å€ãã«
ãã»ã«ãé¡ç²åã³åº§è¬ã®è£œé ã«çšããããšãã§
ããããã«ãã€ãŠåºåœ¢å€åã®ãµãªãã«é žã³ãªã³ã
åŸãããã
c.c.äžã«æº¶è§£ãã溶液ãå ¥ããããã«ãµãªãã«é ž
138ïœãäžå®ã®æ¹æäžã«äºé žåççŽ ã®ããã ã¡ã
æ¢ããŸã§å ãããããããŠèª¿è£œãããµãªãã«é žã³
ãªã³æº¶æ¶²ãæ¿çž®ããŠããµãªãã«é žã³ãªã³ã®æ¿åºŠã
ééæ¯ã§å°ãªããšã溶液ã®90ïŒ ã«ãªãããã«ããŸ
ã10ïŒ ä»¥äžã®æ°Žãæ®ããªãããã«ããããã®æº¶æ¶²
ã«ãµãªãã«é žãã°ãã·ãŠã ç¡æ°Žç©300ïœãå ãã
æ··åç©ãæ¹æããããã°ãããããšããŒã¹ãç¶ã®
ãããŸãã圢æãããããã¬ã©ã¹ã®è¡šé¢äžã«å¡åž
ããŠä¹Ÿç¥ããããããæ°æéã§ç¡¬ãåºäœç©è³ªãåŸ
ããããããç²ç ããŠåŸ®çŽ°ãªç²æ«ã«ããŠé å€ãã«
ãã»ã«ãé¡ç²åã³åº§è¬ã®è£œé ã«çšããããšãã§
ããããã«ãã€ãŠåºåœ¢å€åã®ãµãªãã«é žã³ãªã³ã
åŸãããã
åŸããããµãªãã«é
žã³ãªã³ãå«æããåºäœç©è³ª
ã¯æ··åç©ã§ãããäŸãã°æ°Žã§åŠçããããšã«ãã€
ãŠåæåã«åé¢ãããã
ã¯æ··åç©ã§ãããäŸãã°æ°Žã§åŠçããããšã«ãã€
ãŠåæåã«åé¢ãããã
å®æœäŸ ïŒ
å®æœäŸïŒã§çšãããµãªãã«é
žãã°ãã·ãŠã ã®ä»£
ããã«ãçã¢ã«éã®ãµãªãã«é žã¢ã«ãããŠã ããµ
ãªãã«é žæ°Žé žåã¢ã«ãããŠã ããµãªãã«é žãã¹ã
ã¹åã³ãµãªãã«é žã«ã«ã·ãŠã ãçšããã䜿çšãã
ãµãªãã«é žã®éå±å¡©ã¯ç¡æ°Žç©ã§ãããå®è³ªçã«äž
çŽç©ãå«ãŸãªããšããããšã¯éèŠã§ãããåŸãã
ãæ··åç©ã¯ãµãªãã«é žã³ãªã³ããå«æããåºåœ¢å€
åã®è£œé ã«èª¿å€äžæå¹ãªæµåæ§ã®ããç²æ«ã§ãã€
ãã
ããã«ãçã¢ã«éã®ãµãªãã«é žã¢ã«ãããŠã ããµ
ãªãã«é žæ°Žé žåã¢ã«ãããŠã ããµãªãã«é žãã¹ã
ã¹åã³ãµãªãã«é žã«ã«ã·ãŠã ãçšããã䜿çšãã
ãµãªãã«é žã®éå±å¡©ã¯ç¡æ°Žç©ã§ãããå®è³ªçã«äž
çŽç©ãå«ãŸãªããšããããšã¯éèŠã§ãããåŸãã
ãæ··åç©ã¯ãµãªãã«é žã³ãªã³ããå«æããåºåœ¢å€
åã®è£œé ã«èª¿å€äžæå¹ãªæµåæ§ã®ããç²æ«ã§ãã€
ãã
å®æœäŸ ïŒ
ééæ¯ã§å°ãªããšã90ïŒ
ã®ãµãªãã«é
žã³ãªã³ã
å«ããµãªãã«é žã³ãªã³æ°Žæº¶æ¶²ã«ãçã¢ã«éã®ãµãª
ãã«é žæ°Žé žåã¢ã«ãããŠã ç¡æ°Žç©ãäžå®ã®æ¹æäž
ã«å ãããããã«ãã€ãŠãããããããç¶ã®
ïŒputtylikeïŒãããŸããåŸãããããã®æ··åç©ã
ããæ··ããªãããæ··åç©äžã«å«ãŸãããµãªãã«é ž
ã³ãªã³åã³ãµãªãã«é žæ°Žé žåã¢ã«ãããŠã ã®ç®è¡
çåèšéã®2.5ä¹è³25ééããŒã»ã³ãã®ã«ã«ãã
ã·ã¡ãã«ã»ã«ããŒã¹ãå ãããšãããããããã
ãŸãã¯æ¥éã«ç¡¬åããããããç²ç ããŠåŸ®çŽ°ãªç²
æ«ã«ãããåŸãããåºäœã®ä¹Ÿç¥ããæ··åç©ã¯ã調
å€çã«å¥œãŸãããµãªãã«é žã³ãªã³ã®åºåœ¢å€åã補
é ããã®ã«æçšãªæµåæ§ãæãã也ç¥ããç²æ«ã§
ãã€ããäžèšã«çšãããµãªãã«é žæ°Žé žåã¢ã«ãã
ãŠã ã®ä»£ããã«ããµãªãã«é žã¢ã«ãããŠã ããµãª
ãã«é žãã°ãã·ãŠã ããµãªãã«é žãã¹ãã¹ããµãª
ãã«é žã«ã«ã·ãŠã ã®éå±å¡©ç¡æ°Žç©ã®ãã¡ã®äžã€ãŸ
ãã¯ãããã®æ··åç©ã®çã¢ã«éã䜿çšããŠãåæ§
ã®çµæãåŸãããã
å«ããµãªãã«é žã³ãªã³æ°Žæº¶æ¶²ã«ãçã¢ã«éã®ãµãª
ãã«é žæ°Žé žåã¢ã«ãããŠã ç¡æ°Žç©ãäžå®ã®æ¹æäž
ã«å ãããããã«ãã€ãŠãããããããç¶ã®
ïŒputtylikeïŒãããŸããåŸãããããã®æ··åç©ã
ããæ··ããªãããæ··åç©äžã«å«ãŸãããµãªãã«é ž
ã³ãªã³åã³ãµãªãã«é žæ°Žé žåã¢ã«ãããŠã ã®ç®è¡
çåèšéã®2.5ä¹è³25ééããŒã»ã³ãã®ã«ã«ãã
ã·ã¡ãã«ã»ã«ããŒã¹ãå ãããšãããããããã
ãŸãã¯æ¥éã«ç¡¬åããããããç²ç ããŠåŸ®çŽ°ãªç²
æ«ã«ãããåŸãããåºäœã®ä¹Ÿç¥ããæ··åç©ã¯ã調
å€çã«å¥œãŸãããµãªãã«é žã³ãªã³ã®åºåœ¢å€åã補
é ããã®ã«æçšãªæµåæ§ãæãã也ç¥ããç²æ«ã§
ãã€ããäžèšã«çšãããµãªãã«é žæ°Žé žåã¢ã«ãã
ãŠã ã®ä»£ããã«ããµãªãã«é žã¢ã«ãããŠã ããµãª
ãã«é žãã°ãã·ãŠã ããµãªãã«é žãã¹ãã¹ããµãª
ãã«é žã«ã«ã·ãŠã ã®éå±å¡©ç¡æ°Žç©ã®ãã¡ã®äžã€ãŸ
ãã¯ãããã®æ··åç©ã®çã¢ã«éã䜿çšããŠãåæ§
ã®çµæãåŸãããã
äžèšã®çšããã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã®ä»£
ããã«ãçééã®ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã
ãŸãã¯ã«ã«ããã·ãããã«ã»ã«ããŒã¹ãŸãã¯ãã
ãã®æ··åç©ã䜿çšããŠãåæ§ã®çµæãåŸãããã
ããã«ãçééã®ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã
ãŸãã¯ã«ã«ããã·ãããã«ã»ã«ããŒã¹ãŸãã¯ãã
ãã®æ··åç©ã䜿çšããŠãåæ§ã®çµæãåŸãããã
äžè¿°ãã倫ã
ã®ã«ã«ããã·äœçŽã¢ã«ãã«ã»ã«ã
ãŒã¹ãŸãã¯ãããã®æ··åç©ã®å¥œãŸããæ¿åºŠé åã¯
ééæ¯ã§2.5ïŒ ä¹è³25ïŒ ã§ãã€ãããæ·»å ããã
ã»ã«ããŒã¹æåã®æé©é åã¯ééæ¯ã§2.5ä¹è³ïŒ
ïŒ ã§ããããªãã§ããã奜é©ãªæ¿åºŠé åã¯ééæ¯
ã§ïŒïŒ ä¹è³ïŒïŒ ã§ãã€ããæ·»å ãã¹ãã«ã«ããã·
ã¢ã«ãã«ã»ã«ããŒã¹ïŒå¥œé©ã«ã¯ã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ïŒã®æ£ç¢ºãªéã¯ãæ··åç©äžã«ååšãã
æ°Žã®éã«ãã€ãŠæ±ºãŸããåŸã€ãŠã溶液äžã®æ°Žã®æ¿
床ãééæ¯ã§10ïŒ ãŸãã¯ãã以äžãªãã°ãééæ¯
ã§15ïŒ ä¹è³25ïŒ ãšé«ãæ¿åºŠé åã®ã«ã«ããã·ã¢ã«
ãã«ã»ã«ããŒã¹ãçšããããæ°Žã®éãééæ¯ã§10
ïŒ ä¹è³15ïŒ ã®å Žåã¯æ·»å ãã¹ãã«ã«ããã·ã¢ã«ã
ã«ã»ã«ããŒã¹ã®éã¯ééæ¯ã§ïŒä¹è³15ïŒ ã§ããã
ãŸãæ°Žã®éãééæ¯ã§10ïŒ ä»¥äžã®å Žåã䜿çšãã
ã«ã«ããã·ã¢ã«ãã«ã»ã«ããŒã¹ã®éã¯ééæ¯ã§
2.5ïŒ ä¹è³ïŒïŒ ã®ç¯å²ã§ãã€ãã
ãŒã¹ãŸãã¯ãããã®æ··åç©ã®å¥œãŸããæ¿åºŠé åã¯
ééæ¯ã§2.5ïŒ ä¹è³25ïŒ ã§ãã€ãããæ·»å ããã
ã»ã«ããŒã¹æåã®æé©é åã¯ééæ¯ã§2.5ä¹è³ïŒ
ïŒ ã§ããããªãã§ããã奜é©ãªæ¿åºŠé åã¯ééæ¯
ã§ïŒïŒ ä¹è³ïŒïŒ ã§ãã€ããæ·»å ãã¹ãã«ã«ããã·
ã¢ã«ãã«ã»ã«ããŒã¹ïŒå¥œé©ã«ã¯ã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ïŒã®æ£ç¢ºãªéã¯ãæ··åç©äžã«ååšãã
æ°Žã®éã«ãã€ãŠæ±ºãŸããåŸã€ãŠã溶液äžã®æ°Žã®æ¿
床ãééæ¯ã§10ïŒ ãŸãã¯ãã以äžãªãã°ãééæ¯
ã§15ïŒ ä¹è³25ïŒ ãšé«ãæ¿åºŠé åã®ã«ã«ããã·ã¢ã«
ãã«ã»ã«ããŒã¹ãçšããããæ°Žã®éãééæ¯ã§10
ïŒ ä¹è³15ïŒ ã®å Žåã¯æ·»å ãã¹ãã«ã«ããã·ã¢ã«ã
ã«ã»ã«ããŒã¹ã®éã¯ééæ¯ã§ïŒä¹è³15ïŒ ã§ããã
ãŸãæ°Žã®éãééæ¯ã§10ïŒ ä»¥äžã®å Žåã䜿çšãã
ã«ã«ããã·ã¢ã«ãã«ã»ã«ããŒã¹ã®éã¯ééæ¯ã§
2.5ïŒ ä¹è³ïŒïŒ ã®ç¯å²ã§ãã€ãã
å®æœäŸ ïŒ
ãµãªãã«é
žã³ãªã³åã³ãµãªãã«é
žãã°ãã·ãŠã
ã®æ··åç©ããæãåºäœã®ãµãªãã«é žã³ãªã³çµæç©
ã®åãéãèšéãããããªç¿ã«åãã宀枩ã«ãã
ãŠå€§æ°äžã«æãã第ïŒæ¥ç®ã¯ïŒæéããšã«ããã®
åŸã¯ïŒæéããšã«ãããªç¿ãæ€æ»ããã倧æ°äžã«
æããŠïŒæ¥åŸã«çŽ8.7ïŒ ã®ééã®å¢å ã枬å®ãã
ãããã®è©Šéšããµãªãã«é žã³ãªã³ããµãªãã«é žã
ã°ãã·ãŠã åã³ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãæ··
åããŠåŸãããåºäœçµæç©ãçšããŠç¹°è¿ãããšã
ããéæŸãããããªç¿ã«å ¥ããŠå€§æ°äžã«æããŠã
ãïŒæ¥åŸã«ééã¯4.2ïŒ å¢å ããã
ã®æ··åç©ããæãåºäœã®ãµãªãã«é žã³ãªã³çµæç©
ã®åãéãèšéãããããªç¿ã«åãã宀枩ã«ãã
ãŠå€§æ°äžã«æãã第ïŒæ¥ç®ã¯ïŒæéããšã«ããã®
åŸã¯ïŒæéããšã«ãããªç¿ãæ€æ»ããã倧æ°äžã«
æããŠïŒæ¥åŸã«çŽ8.7ïŒ ã®ééã®å¢å ã枬å®ãã
ãããã®è©Šéšããµãªãã«é žã³ãªã³ããµãªãã«é žã
ã°ãã·ãŠã åã³ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ãæ··
åããŠåŸãããåºäœçµæç©ãçšããŠç¹°è¿ãããšã
ããéæŸãããããªç¿ã«å ¥ããŠå€§æ°äžã«æããŠã
ãïŒæ¥åŸã«ééã¯4.2ïŒ å¢å ããã
äžèšããåºäœã®ãµãªãã«é
žã³ãªã³çµæç©ãçšã
ãè©Šéšã®å šãŠã«ãããŠãæµåæ§ãæããç²æ«ã®æ§
質ã¯ïŒæ¥é倧æ°äžã«æããåŸãå€åããªãã€ãã
ãè©Šéšã®å šãŠã«ãããŠãæµåæ§ãæããç²æ«ã®æ§
質ã¯ïŒæ¥é倧æ°äžã«æããåŸãå€åããªãã€ãã
äžæ¹ãç±³åœç¹èš±ç¬¬3069321å·ã«é瀺ãããæ¹æ³
ã«ãã€ãŠè£œé ãããèç¹çŽ50âã®çµæ¶ç¶ãµãªãã«
é žã³ãªã³ã®åãéãå¥ã®ãããªç¿ã«åãã倧æ°äž
ã«æãããšãããïŒæéåŸã«æ¶²åããã
ã«ãã€ãŠè£œé ãããèç¹çŽ50âã®çµæ¶ç¶ãµãªãã«
é žã³ãªã³ã®åãéãå¥ã®ãããªç¿ã«åãã倧æ°äž
ã«æãããšãããïŒæéåŸã«æ¶²åããã
å®æœäŸ ïŒ
äžèšã®å®æœäŸïŒä¹è³å®æœäŸïŒã®çµæãšããŠåŸã
ããåºäœã®ãµãªãã«é žã³ãªã³çµæç©ã®åºäœç¶æ ã
ç¶æããèœåãã倫ã ã®çµæç©ã®ãµã³ãã«ïŒïœã
倧æ°äžã«æãããŸãèšéããã¬ã©ã¹ç¿ã«å ¥ããŠ
倫ã ç°ãªã€ã倧æ°æ¡ä»¶äžïŒæž©åºŠ37âã«ãããŠæ¹¿åºŠ
ã97ïŒ ãŸã§å€åããããïŒã§ä¿ç®¡ããããšã«ãã€
ãŠè©äŸ¡ãããåãã€ãŠæ±ºããããäžå®ã®æééé
ã§ãµã³ãã«ãæ€æ»ããæãããç²æ«ã®ç©çç¶æ ã
èšé²ããã
ããåºäœã®ãµãªãã«é žã³ãªã³çµæç©ã®åºäœç¶æ ã
ç¶æããèœåãã倫ã ã®çµæç©ã®ãµã³ãã«ïŒïœã
倧æ°äžã«æãããŸãèšéããã¬ã©ã¹ç¿ã«å ¥ããŠ
倫ã ç°ãªã€ã倧æ°æ¡ä»¶äžïŒæž©åºŠ37âã«ãããŠæ¹¿åºŠ
ã97ïŒ ãŸã§å€åããããïŒã§ä¿ç®¡ããããšã«ãã€
ãŠè©äŸ¡ãããåãã€ãŠæ±ºããããäžå®ã®æééé
ã§ãµã³ãã«ãæ€æ»ããæãããç²æ«ã®ç©çç¶æ ã
èšé²ããã
ç±³åœç¹èš±ç¬¬3069321å·ã«åŸã€ãŠè£œé ããèç¹
49.3âã®ãµãªãã«é žã³ãªã³ã¯å šãŠã®æž©åºŠã«ããã
å®éšã«ãããŠãæããŠããïŒå以å ã«æ¶²åããã
49.3âã®ãµãªãã«é žã³ãªã³ã¯å šãŠã®æž©åºŠã«ããã
å®éšã«ãããŠãæããŠããïŒå以å ã«æ¶²åããã
ç±³åœç¹èš±ç¬¬3759980å·ã«åŸã€ãŠè£œé ãããã°ã
ã·ãŠã ã³ãªã³ãµãªãã¬ãŒãã¯å€§æ°äžã«æããå Ž
åã枩床37âã湿床60ïŒ ã§ã¯32æéåŸã枩床37
âã湿床80ïŒ ã§ã¯20æéåŸã枩床37âã湿床90ïŒ
ã§ã¯18æéåŸã«å€«ã 液åããã
ã·ãŠã ã³ãªã³ãµãªãã¬ãŒãã¯å€§æ°äžã«æããå Ž
åã枩床37âã湿床60ïŒ ã§ã¯32æéåŸã枩床37
âã湿床80ïŒ ã§ã¯20æéåŸã枩床37âã湿床90ïŒ
ã§ã¯18æéåŸã«å€«ã 液åããã
å®æœäŸïŒã®çµæãšããŠåŸããããµãªãã«é
žã³ãª
ã³ãšãµãªãã«é žãã°ãã·ãŠã ã®æ··åç©ã¯å€§æ°äžã«
æããå Žåã枩床37âã湿床60ïŒ ã§ã¯30æéåŸã
枩床37âã湿床80ïŒ ã§ã¯24æéåŸã枩床37âã湿
床90ïŒ ã§ã¯20æéåŸã«å€«ã 液åããã
ã³ãšãµãªãã«é žãã°ãã·ãŠã ã®æ··åç©ã¯å€§æ°äžã«
æããå Žåã枩床37âã湿床60ïŒ ã§ã¯30æéåŸã
枩床37âã湿床80ïŒ ã§ã¯24æéåŸã枩床37âã湿
床90ïŒ ã§ã¯20æéåŸã«å€«ã 液åããã
å®æœäŸïŒã®çµæãšããŠåŸãããããµãªãã«é
žã
ã°ãã·ãŠã ãšãµãªãã«é žã³ãªã³ãšã«ã«ããã·ã¡ã
ã«ã»ã«ããŒã¹ãšã®æ··åç©ã¯å€§æ°äžã«æããå Žåã
枩床ïŒ37âã湿床60ïŒ ã§ã¯ïŒæ¥åŸã«ã枩床37âã
湿床80ïŒ ã§ã¯ïŒæ¥åŸã«ã枩床37âã湿床90ïŒ ã§ã¯
2.5æ¥åŸã«å€«ã 液åããã
ã°ãã·ãŠã ãšãµãªãã«é žã³ãªã³ãšã«ã«ããã·ã¡ã
ã«ã»ã«ããŒã¹ãšã®æ··åç©ã¯å€§æ°äžã«æããå Žåã
枩床ïŒ37âã湿床60ïŒ ã§ã¯ïŒæ¥åŸã«ã枩床37âã
湿床80ïŒ ã§ã¯ïŒæ¥åŸã«ã枩床37âã湿床90ïŒ ã§ã¯
2.5æ¥åŸã«å€«ã 液åããã
å®æœäŸïŒã®çµæãšããŠåŸããããµãªãã«é
žã¢ã«
ãããŠã ãšãµãªãã«é žã³ãªã³ã®æ··åç©ã¯å€§æ°äžã«
æããå Žåã枩床37âã湿床80ïŒ ã§ã¯ïŒæ¥åŸãæž©
床37âã湿床90ïŒ ã§ã¯çŽïŒæ¥ïŒ3.2æ¥ïŒåŸã«å€«ã
液åããã
ãããŠã ãšãµãªãã«é žã³ãªã³ã®æ··åç©ã¯å€§æ°äžã«
æããå Žåã枩床37âã湿床80ïŒ ã§ã¯ïŒæ¥åŸãæž©
床37âã湿床90ïŒ ã§ã¯çŽïŒæ¥ïŒ3.2æ¥ïŒåŸã«å€«ã
液åããã
å®æœäŸïŒã®çµæãšããŠåŸããããµãªãã«é
žã¢ã«
ãããŠã ãšãµãªãã«é žã³ãªã³ãšã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ãšã®æ··åç©ã¯å€§æ°äžã«æããå Žåãæž©
床37âã湿床80ïŒ ã§ã¯çŽïŒæ¥ïŒ4.3æ¥ïŒåŸã«ãæž©
床37âã湿床90ïŒ ã§ã¯3.5æ¥åŸã«å€«ã 液åããã
ãããŠã ãšãµãªãã«é žã³ãªã³ãšã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ãšã®æ··åç©ã¯å€§æ°äžã«æããå Žåãæž©
床37âã湿床80ïŒ ã§ã¯çŽïŒæ¥ïŒ4.3æ¥ïŒåŸã«ãæž©
床37âã湿床90ïŒ ã§ã¯3.5æ¥åŸã«å€«ã 液åããã
å®æœäŸ ïŒ
æ®éã®ã¢ã¹ããªã³é å€ïŒé ã®ãµãªãã«é
žå«æé
ã«ã»ãŒå¹æµããçŽ435mgã®ãµãªãã«é žã³ãªã³ãå«
æããé å€ãäœæããããã«ãå®æœäŸïŒä¹è³å®æœ
äŸïŒã§åŸãããæ··åç©ãèšéããéåžžã®é å€è£œé
æ³åã³è³Šåœ¢å€ãçšããŠå§çž®ããé å€ã圢æããã
ã«ã»ãŒå¹æµããçŽ435mgã®ãµãªãã«é žã³ãªã³ãå«
æããé å€ãäœæããããã«ãå®æœäŸïŒä¹è³å®æœ
äŸïŒã§åŸãããæ··åç©ãèšéããéåžžã®é å€è£œé
æ³åã³è³Šåœ¢å€ãçšããŠå§çž®ããé å€ã圢æããã
å®æœäŸ ïŒ
å®æœäŸïŒä¹è³å®æœäŸïŒã§åŸãããæ··åç©ã®é©åœ
éãèšéããé©åœãªå€§ããã®ãŒã©ãã³ã«ãã»ã«ã«
å å¡«ãããµãªãã«é žå«æé325mgã®ã¢ã¹ããªã³é
å€ãšã»ãŒå¹æµããå°ãªããšã435mgã®ãµãªãã«é ž
ã³ãªã³ãå«æããåäœæçšåœ¢ãäœæãããããå¿
èŠãªãäžæŽ»æ§ã§é©åæ§ã®ããé©åœãªã«ãã»ã«è³Šåœ¢
å€ãçšããŠãè¯ãã
éãèšéããé©åœãªå€§ããã®ãŒã©ãã³ã«ãã»ã«ã«
å å¡«ãããµãªãã«é žå«æé325mgã®ã¢ã¹ããªã³é
å€ãšã»ãŒå¹æµããå°ãªããšã435mgã®ãµãªãã«é ž
ã³ãªã³ãå«æããåäœæçšåœ¢ãäœæãããããå¿
èŠãªãäžæŽ»æ§ã§é©åæ§ã®ããé©åœãªã«ãã»ã«è³Šåœ¢
å€ãçšããŠãè¯ãã
ãããã©ã®ãããªå€åã§ãããã«ãããããæ¬
çºæã®æ··åç©ã¯ããããæäžããããšã«ãã€ãŠè¡
äžã®ãµãªãã¬ãŒãã€ãªã³æ¿åºŠãäžæãããããã
æ²»çäžã®ç®çã®ããã«äœ¿çšãããããããããã
ãã®æ··åç©ã¯åºåœ¢å€åïŒäŸãã°é å€ãé¡ç²ãã«ã
ã»ã«ãŸãã¯åº§è¬ïŒãšããŠæäžããããšãã§ãããš
ããå©ç¹ãæããã
çºæã®æ··åç©ã¯ããããæäžããããšã«ãã€ãŠè¡
äžã®ãµãªãã¬ãŒãã€ãªã³æ¿åºŠãäžæãããããã
æ²»çäžã®ç®çã®ããã«äœ¿çšãããããããããã
ãã®æ··åç©ã¯åºåœ¢å€åïŒäŸãã°é å€ãé¡ç²ãã«ã
ã»ã«ãŸãã¯åº§è¬ïŒãšããŠæäžããããšãã§ãããš
ããå©ç¹ãæããã
æ¬æ现æžãéããŠãçµæç©ãŸãã¯æ··åç©ã®è°è«
ã¯äž»ãšããŠã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã«ã€ããŠ
ãªããããããããã«ã«ããã·ãšãã«ã»ã«ããŒ
ã¹ãã«ã«ããã·ãããã«ã»ã«ããŒã¹ãã®ãããªã«
ã«ããã·äœçŽã¢ã«ãã«ã»ã«ããŒã¹ãªãã©ãã§ã䜿
çšã§ããããšãç解ãããããã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ã¯æçšæ§åã³çµæžæ§ã®èŠ³ç¹ããæã奜
ãŸãããã®ã§ãããšããããšã«ãããªãã
ã¯äž»ãšããŠã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã«ã€ããŠ
ãªããããããããã«ã«ããã·ãšãã«ã»ã«ããŒ
ã¹ãã«ã«ããã·ãããã«ã»ã«ããŒã¹ãã®ãããªã«
ã«ããã·äœçŽã¢ã«ãã«ã»ã«ããŒã¹ãªãã©ãã§ã䜿
çšã§ããããšãç解ãããããã«ã«ããã·ã¡ãã«
ã»ã«ããŒã¹ã¯æçšæ§åã³çµæžæ§ã®èŠ³ç¹ããæã奜
ãŸãããã®ã§ãããšããããšã«ãããªãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãµãªãã«é žã³ãªã³ãšãå°ãªããšãïŒäŸ¡ã®åå
䟡ãæããå°ãªããšãïŒçš®é¡ã®ççåŠçã«é©åã
ãéå±ã®ãµãªãã«é žå¡©ãšãã«ã«ããã·äœçŽã¢ã«ã
ã«ã»ã«ããŒã¹ãšã®æ··åç©ããæãããšãç¹åŸŽãšã
ããµãªãã«é žã³ãªã³ãå«æããå®å®ãªåºäœè¬å€çš
çµæç©ã ïŒ åèšã®éå±ãã¢ã«ãããŠã ããã¹ãã¹ãã«ã«
ã·ãŠã åã³ãã°ãã·ãŠã ããæã矀ããéžã°ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®åºäœè¬å€çšçµæ
ç©ã ïŒ åèšã®éå±ããã°ãã·ãŠã ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã«èšèŒã®åºäœè¬å€çšçµæç©ã ïŒ åèšã®ã«ã«ããã·äœçŽã¢ã«ãã«ã»ã«ããŒã¹ã
ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé ã«èšèŒã®åºäœè¬å€çšçµæç©ã ïŒ åèšã®ã«ã«ããã·äœçŽã¢ã«ãã«ã»ã«ããŒã¹ã
ééæ¯ã§2.5ïŒ ä¹è³40ïŒ å«æããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®åºäœè¬å€çšçµæç©ã ïŒ èª¿å€çã«å¥œé©ãªåºäœã®è³Šåœ¢å€ããå«ã¿ã人é
åã³åç©ã«å¯Ÿãããµãªãã«é žã³ãªã³æäžçæ³ã®ã
ãã®èª¿å€äžã®åºåœ¢å€åã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã«èšèŒã®åºäœè¬å€çšçµæç©ã ïŒ ïŒåã®æçšéåœã435mgã®ãµãªãã«é žã³ãªã³
ãäžããéã®åºåœ¢å€ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®åºäœè¬å€çšçµæç©ã
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65111076A | 1976-01-21 | 1976-01-21 | |
US651110 | 1976-01-21 | ||
US705056 | 1976-07-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60252415A JPS60252415A (ja) | 1985-12-13 |
JPH0344052B2 true JPH0344052B2 (ja) | 1991-07-04 |
Family
ID=24611611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60082690A Granted JPS60252415A (ja) | 1976-01-21 | 1985-04-19 | ãµãªãã«é žã³ãªã³ãå«æããå®å®ãªåºäœè¬å€çšçµæç© |
Country Status (6)
Country | Link |
---|---|
US (1) | US4067974A (ja) |
JP (1) | JPS60252415A (ja) |
AT (1) | AT353988B (ja) |
BE (1) | BE850449A (ja) |
IN (1) | IN145525B (ja) |
ZA (1) | ZA767679B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338311A (en) * | 1980-10-27 | 1982-07-06 | Riker Laboratories, Inc. | Hydrophilic choline salicylate formulation |
US5043168A (en) * | 1990-04-26 | 1991-08-27 | Sidmak Laboratories, Inc. | Solid choline magnesium salicylate composition and method of preparing same |
US5217965A (en) * | 1991-06-17 | 1993-06-08 | Euroceltique, S.A. | Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
ZA200409537B (en) * | 2003-01-31 | 2006-10-25 | Yamanouchi Pharma Co Ltd | Stable solid medicinal composition for oral administration |
US7358270B2 (en) * | 2004-01-30 | 2008-04-15 | Astellas Pharma Inc. | Treating agent for irritable bowel syndrome |
US20060293218A1 (en) * | 2005-06-22 | 2006-12-28 | Meythaler Jay M | Salicylate therapeutic compound and process for controlled delivery thereof |
US20100075930A1 (en) * | 2008-09-03 | 2010-03-25 | Yoel Ovil | Salicylic salt compositions and related method of treatment of cardiac conditions |
US8828979B2 (en) | 2012-03-27 | 2014-09-09 | Essential Ingredients, Inc. | Salicylic acid gel |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3759980A (en) * | 1969-05-26 | 1973-09-18 | Stockton Chemicals Inc | Salicylates |
JPS526319A (en) * | 1975-07-04 | 1977-01-18 | Chugai Ro Kogyo Kaisha Ltd | Three-way firing heat treatment furnace |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3347744A (en) * | 1963-10-25 | 1967-10-17 | Smith Kline French Lab | Magnesium hydroxide suspensions |
US3326760A (en) * | 1966-05-17 | 1967-06-20 | Synergistics Inc | Choline salicylate polygalacturonate therapy |
-
1976
- 1976-07-14 US US05/705,056 patent/US4067974A/en not_active Expired - Lifetime
- 1976-12-08 IN IN2173/CAL/76A patent/IN145525B/en unknown
- 1976-12-29 ZA ZA767679A patent/ZA767679B/xx unknown
-
1977
- 1977-01-17 BE BE174130A patent/BE850449A/xx not_active IP Right Cessation
- 1977-01-20 AT AT34677A patent/AT353988B/de not_active IP Right Cessation
-
1985
- 1985-04-19 JP JP60082690A patent/JPS60252415A/ja active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3759980A (en) * | 1969-05-26 | 1973-09-18 | Stockton Chemicals Inc | Salicylates |
JPS526319A (en) * | 1975-07-04 | 1977-01-18 | Chugai Ro Kogyo Kaisha Ltd | Three-way firing heat treatment furnace |
Also Published As
Publication number | Publication date |
---|---|
BE850449A (fr) | 1977-05-16 |
AT353988B (de) | 1979-12-10 |
JPS60252415A (ja) | 1985-12-13 |
ATA34677A (de) | 1979-05-15 |
IN145525B (ja) | 1978-10-28 |
US4067974A (en) | 1978-01-10 |
ZA767679B (en) | 1977-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2990328A (en) | Stable therapeutic compositions containing acetylsalicylic acid-anhydride | |
US5211958A (en) | Pharmaceutical composition and process for its preparation | |
JP2001518500A (ja) | å§çž®ããããããã°ãªã»ãªã³é å€ãšãã®è£œé æ¹æ³ | |
HU224983B1 (en) | Swallow tablet comprising paracetamol | |
KR0177493B1 (ko) | ëšì¬ì ê³ ê²°ì 구조륌 ê°ê³ ê°ìŽ, ê°êŽ ë° ê°ìµì±ìŽ ìë íì±ì±ë¶ì íšì íë ì ì ì ì ì¡°ë°©ë² | |
JPH0344052B2 (ja) | ||
US4666919A (en) | Stabilized pharmaceutical composition containing an isocarbostyril derivative | |
JPWO2015099139A1 (ja) | ããã°ãªãããžã³ãå«æããåºåœ¢è£œå€åã³ãã®è£œé æ¹æ³ | |
SK281193B6 (sk) | Tableta so zlepÅ¡enou biodostupnosÅ¥ou úÄinnej látky, kyseliny klodrónovej, spÃŽsob jej vÃœroby a pouÅŸitie mikrokryÅ¡talickej celulózy | |
JP2901635B2 (ja) | ã¢ã«ã®ããŒããšããªã¢ã¯ãªã¬ãŒãã®æ··åç©åã³ãã®äœ¿çš | |
ES2732711T3 (es) | Composición farmacéutica estable sólida de citisina y proceso para la preparación de la misma | |
FI89455B (fi) | Foerfarande foer framstaellning av en farmaceutisk komposition | |
GB1575977A (en) | Solid choline salicylate compositions | |
KR100267525B1 (ko) | ìíëŒë¹ ì¥í¬ì€íìŽíž ê²œì§ ìº¡ìì | |
RU2240784C1 (ru) | ÐекаÑÑÑвеММПе ÑÑеЎÑÑвП Ма ПÑМПве аÑбОЎПла | |
JP2594395B2 (ja) | ã¢ãºã¬ã³ã¹ã«ãã³é žãããªãŠã ã®å®å®åæ³ããã³è£œå€ | |
US3326760A (en) | Choline salicylate polygalacturonate therapy | |
JPH03120211A (ja) | ç²ç¶ã«ã«ããã³è£œå€ | |
US20060189565A1 (en) | Pharmaceutical compositions of ganciclovir | |
RU2248205C1 (ru) | ÐекаÑÑÑвеММПе ÑÑеЎÑÑвП в вОЎе желаÑОМПвПй капÑÑÐ»Ñ | |
JP2001354566A (ja) | ãã»ã«ãŽãªã³ã®é å€ | |
US3131121A (en) | Highly acidic cation exchange resin containing amprotropine cations | |
US4338311A (en) | Hydrophilic choline salicylate formulation | |
JP2013209369A (ja) | ãããœãããã§ã³ãããªãŠã ãšå¶é žå€ãå«æããåºåœ¢è£œå€ | |
RU2110258C1 (ru) | СпПÑПб пПлÑÑÐµÐœÐžÑ ÐºÐŸÐŒÐ±ÐžÐœÐžÑПваММПгП лекаÑÑÑвеММПгП пÑепаÑаÑа в ÑвеÑÐŽÑÑ Ð¶ÐµÐ»Ð°ÑОМПвÑÑ ÐºÐ°Ð¿ÑÑÐ»Ð°Ñ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |